Patent · US Active

Methods of treating inflammation using mammalian CX3C chemokine antibodies

US7431924B2 · kind B2 · utility

5Cited by
4References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 28, 2006
Grant dateOct 7, 2008
Priority date
Expiry dateJul 28, 2026

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/81
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.